GlassScriptPhysician profile
Jason Kirk Lowry
NPI 1548296841
$4,509.89
in general payments reported to CMS, 2019-2025
15 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,174 · 2020: $28.95 · 2021: $1,390 · 2022: $329 · 2023: $224 · 2024: $206 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,124.40 | 2019-2024 | Persona, Mymobility Platform |
| Smith+Nephew, INC. | $659.17 | 2019 | |
| Stryker Corporation | $502.19 | 2019-2021 | |
| Depuy Synthes Sales INC. | $304.45 | 2019-2024 | Monovisc |
| Horizon Therapeutics Plc | $165.68 | 2019-2020 | |
| Microport Orthopedics INC | $154.12 | 2019 | |
| Gt Medical Technologies, INC | $140.36 | 2023 | Gammatile |
| Ferring Pharmaceuticals INC. | $108.41 | 2019-2025 | Euflexxa |
| Pylant Medical | $104.97 | 2022-2024 | |
| Pacira Therapeutics, INC. | $100.40 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $64.74 | 2025 | |
| Curonix LLC | $29.52 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Pharmaceuticals Incorporated | $20.57 | 2025 | Zilretta, Iovera |
| Bioventus LLC | $19.86 | 2019 | |
| Fidia Pharma USA INC. | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Lowry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.